Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome Treatment in Androgenetic Alopecia
NCT06539273Phase 3Completed
- Sponsor
- Yeditepe University Hospital
- Start
- Jan 2024
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in androgenetic alopecia (AGA), sponsored by Yeditepe University Hospital. Primary endpoint: Hair density at 12 weeks. Started Jan 2024; status: completed.
02
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06539273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06539273.